Fighting the spread of viruses: Producing cheap vaccines, quickly

(Medical Xpress)—Immunising people with vaccines that are quick and inexpensive to produce is the answer to preventing large-scale spread of infectious disease, Professor Anton Middelberg from UQ's Australian Institute for Bioengineering and Nanotechnology says.

Using modern molecular and bioprocessing tools, Professor Middelberg and his team are developing vaccines that can be changed and manufactured for the entire Australian population within days of a appearing.

"The new vaccines we are developing are also much cheaper to mass-produce than traditional technologies, so are relevant where cost is an issue – for example, in the ," Professor Middelberg said.

"We use biotechnology to create the safe parts of a virus, and then we use nanotechnology to assemble these building blocks into a virus-like particle (VLP) in a reactor.

"VLPs resemble viruses but, as they only use the safe part of the virus, they are not infectious.

"However, being a safe mimic of the dangerous virus, they raise an excellent .

"Biotechnology allows us to make VLPs rapidly using bacteria, and the VLPs can be manipulated within reactors (not cells) to change composition and the new disease-causing agent.

"This enables an incredibly fast response to new threats."

Professor Middelberg said vaccines needed to be affordable.

"They need to be quickly mass produced once we identify a mutated or new virus – and certainly before it causes widespread disease," he said.

Current are made using egg-based technologies first developed in the 1930s.

"If we are surprised by a sudden change, as with in 2009, people die while they wait for the vaccine composition to 'catch up' with the new virus,"
Professor Middelberg said.

"This issue of speed is also critical for other new and emerging viruses that may invade from overseas, or even locally.

"We simply can't make vaccines fast enough.

"Such radical re-engineering of the system we use to make and deliver new vaccines will have a huge impact on how we can prevent disease, particularly in developing countries, and will bolster another old saying, 'prevention is better than cure'."

add to favorites email to friend print save as pdf

Related Stories

Novel pandemic flu vaccine effective against H5N1 in mice

Mar 01, 2009

Vaccines against H5N1 influenza will be critical in countering a possible future pandemic. Yet public health experts agree that the current method of growing seasonal influenza vaccines in chicken eggs is slow and inefficient.

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

Nov 20, 2014

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.